Angiosarcoma of the residual breast after conservative surgery and radiotherapy for primary carcinoma

L. Del Mastro, O. Garrone, M. Guenzi, F. Cafiero, G. Nicolo, R. Rosso, M. Venturini

Research output: Contribution to journalArticlepeer-review


Background: Angiosarcoma of residual breast, arising after conservative surgery and radiotherapy for early breast cancer, is a rare tumor, with only 14 cases having so far been documented. The first was observed in 1987 and 7 of the 14 were reported in 1992 alone. Methods: Here, we present an additional case developing in residual breast 3.3 years after lumpectomy and radiotherapy. The other fourteen are reviewed. Results: Review of data from this series of patients reveals a higher incidence of breast oedema (67%) than that reported in the literature (4%). Another unusual finding is the shorter mean latency period (time interval from radiotherapy to onset of angiosarcoma) noted here (6 years) compared to the more than 10 years reported for other secondary angiosarcomas. Conclusions: In view of the widespread use of radiotherapy after breast-conserving surgery, and also its lack of benefit in terms of overall survival, every novel complication should be investigated. Given the apparent rise in incidence of this rare tumor over the last few years, doctors should be aware of the phenomenon in order to recognize and define it.

Original languageEnglish
Pages (from-to)163-165
Number of pages3
JournalAnnals of Oncology
Issue number2
Publication statusPublished - 1994


  • angiosarcoma
  • breast angiosarcoma
  • radiotherapy and angiosarcoma
  • review

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Public Health, Environmental and Occupational Health
  • Neuropsychology and Physiological Psychology
  • Hematology


Dive into the research topics of 'Angiosarcoma of the residual breast after conservative surgery and radiotherapy for primary carcinoma'. Together they form a unique fingerprint.

Cite this